SUV Max as Predictor of Outcome in Cervical Cancer
Cervical Cancer is staged clinically, not surgically. Patients in whom an extensive disease is identified are not usually eligible for surgery. PET-CT is used to support staging. However, some patients received surgery after staging and subsequently require radio/chemotherapy due to findings on operation.
This study will attempt to find a correlation between SUV-Max on PET-CT and subsequent outcomes i.e. need for adjuvant therapy.
|Study Design:||Observational Model: Case-Only
Time Perspective: Retrospective
|Official Title:||A Study to Evaluate the Value of SUV-Max in PET-FDG in Predicting Outcome of Surgery Vis a Vis Need for Radiotherapy|
- Administration of adjuvant therapy [ Time Frame: immediately following surgery ] [ Designated as safety issue: No ]
- Overall survival [ Time Frame: surgery - present day ] [ Designated as safety issue: No ]
|Study Start Date:||August 2010|
Radiotherapy for cervical cancer
Please refer to this study by its ClinicalTrials.gov identifier: NCT01262144
|Rambam Medical Center|
|City, Haifa, Israel|
|Principal Investigator:||Amnon Amit, MD||Rambam Health Care Campus|